Louw, Jakobus MurrayRantloane, B.Ngcobo, SaneleBrey, Z.Hugo, Johannes F.M.Basu, DebashisWishnia, J.Christian, C.Pitsi, M.Makhudu, M.Seane, S.Lukhele, M.2021-11-092021-11-092020-08Louw, J.M., Rantloane, B., Ngcobo, S. et al. 2020, 'Home delivery of medication as part of reducing congestion in primary healthcare in Tshwane District Health Services', South African Medical Journal, vol. 4, no. 2, pp. 50-55.0256-9574 (print)2078-5135 (online)10.7196/SHS.2020.v4.i2.124http://hdl.handle.net/2263/82593BACKGROUND. Congestion at health facilities poses the risk of extensive spread of the severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) to patients at high risk for severe illness and death due to this infection. During the lockdown to control the spread of the virus, many patients with chronic conditions are not visiting health facilities and not collecting their chronic medication. To improve adherence to medication, home delivery of medication was instituted for patients with chronic diseases who had been receiving care at the Skinner Street Clinic in Tshwane. OBJECTIVE. To support patients with chronic diseases who were unable to collect their medication, by remotely consulting (telehealth) and delivering their medication during the lockdown due to the COVID-19 pandemic. METHODS. Patients were identified for potential home delivery of medication from the clinic appointment book. Their files were retrieved, and they were telephoned and offered the option of receiving medication through home delivery instead of attending a health facility. For those who qualified and accepted home delivery, files were sent to the clinic pharmacy. Medication parcels were prepared and sent to ward-based outreach teams to deliver to patients. Relevant information was captured on the Qualtrics platform. RESULTS. A total of 1 727 files were evaluated. Of these patients, 60% were on treatment for HIV infection, and 19% for hypertension. A total of 32% (n=547) were eligible for home delivery of medication, but only 25% of the 1727 patients accepted the home delivery of medication. Almost 25% could not be contacted. Compared with those with non-communicable diseases (NCDs) or a combination of HIV and one or more NCDs, a higher proportion of HIV-positive patients with no other diagnosis chose not to have their medication delivered at home. Patients using the service expressed their appreciation and requested that it be extended to others. CONCLUSION. Home delivery of medication has significant advantages for patients. It can ensure that patients continue to adhere to their chronic medication in the midst of the COVID-19 epidemic, without increasing their risk of contracting the virus. Expanding the home delivery of medication to more facilities while aligning it with the Centralised Chronic Medicine Dispensing and Distribution programme has the potential to alleviate the congestion and workload of primary care facilities while these are under severe pressure owing to the COVID-19 pandemic.en© 2020 Health & Medical Publishing Group. This journal is protected by a Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0).PatientsLockdownChronicMedicationHome delivery of medicationPrimary healthcare (PHC)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19 pandemicCoronavirus disease 2019 (COVID-19)Non-communicable diseases (NCDs)Health sciences articles SDG-03SDG-03: Good health and well-beingArticle